United States Biotechnology & Medical Research

Kuvatris Therapeutics Inc (PXMD)

Track

Ticker: PXMD Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 29 Jan 2024
Value US$1,423,338.95 | Price 188.28 | Shares 97,885 (-11.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-31 2024-01-29 PlS Planned sale
Weisman Howard J.

Chief Executive Officer

Executive Director
97,885 -11.6%
188.28
US$1,423,339 		97,885 -11.6% 188.28 US$1,423,339
2024-01-31 2024-01-29 PlS Planned sale
LaRochelle Karen
Non-Executive Director
79,108 -8.1%
309.50
US$1,871,804 		79,108 -8.1% 309.50 US$1,871,804
2024-01-31 2024-01-29 PlS Planned sale
Coelho John F
Non-Executive Director
47,904 +46.9%
248.91
US$344,968 		47,904 +46.9% 248.91 US$344,968
2024-01-31 2024-01-29 PlS Planned sale
Rome Zachary
Non-Executive Director
811 -5.1%
0.48
US$389 		811 -5.1% 0.48 US$389
2023-11-29 2023-11-27 PlS Planned sale
Coelho John F
Non-Executive Director
12 -0.3%
1.03
US$12 		12 -0.3% 1.03 US$12
2023-11-29 2023-11-27 PlS Planned sale
Rome Zachary
Non-Executive Director
359 -2.2%
1.03
US$370 		359 -2.2% 1.03 US$370
2023-11-29 2023-11-27 PlS Planned sale
Weisman Howard J.

Chairman and CEO

Executive Director
162 -0.4%
1.03
US$166 		162 -0.4% 1.03 US$166
2023-11-29 2023-11-27 PlS Planned sale
0.5
Derby Michael
Large shareholder
185 -0.7%
1.03
US$190 		185 -0.7% 1.03 US$190
2023-11-29 2023-11-27 PlS Planned sale
LaRochelle Karen
Non-Executive Director
35 -1.2%
1.03
US$36 		35 -1.2% 1.03 US$36
2023-10-30 2023-10-27 PlS Planned sale
LaRochelle Karen
Non-Executive Director
1,679 -3.2%
0.19
US$317 		1,679 -3.2% 0.19 US$317
2023-10-30 2023-10-27 PlS Planned sale
Rome Zachary
Non-Executive Director
16,301 -5.6%
0.18
US$3,012 		16,301 -5.6% 0.18 US$3,012
2023-10-30 2023-10-27 PlS Planned sale
Coelho John F
Non-Executive Director
570 -0.7%
0.19
US$108 		570 -0.7% 0.19 US$108
2023-10-30 2023-10-27 PlS Planned sale
0.5
Derby Michael
Large shareholder
9,175 -2.0%
0.19
US$1,740 		9,175 -2.0% 0.19 US$1,740
2023-10-30 2023-10-27 PlS Planned sale
Weisman Howard J.

Chairman and CEO

Executive Director
8,049 -1.2%
0.19
US$1,524 		8,049 -1.2% 0.19 US$1,524
2023-08-30 2023-08-30 PlS Planned sale
Weisman Howard J.

Chairman and CEO

Executive Director
22,535 -3.3%
0.45
US$10,053 		22,535 -3.3% 0.45 US$10,053
2023-08-30 2023-08-30 PlS Planned sale
Rome Zachary
Non-Executive Director
4,801 -1.6%
0.47
US$2,235 		4,801 -1.6% 0.47 US$2,235
2023-08-30 2023-08-29 PlS Planned sale
0.5
Derby Michael
Large shareholder
6,540 -1.4%
0.48
US$3,169 		6,540 -1.4% 0.48 US$3,169
2023-08-30 2023-08-29 PlS Planned sale
LaRochelle Karen
Non-Executive Director
456 -0.9%
0.48
US$221 		456 -0.9% 0.48 US$221
2023-08-30 2023-08-29 PlS Planned sale
Coelho John F
Non-Executive Director
23 -0.0%
0.49
US$11 		23 -0.0% 0.49 US$11
2023-08-30 2023-08-29 PlS Planned sale
Weisman Howard J.

Chairman and CEO

Executive Director
9,596 -1.4%
0.48
US$4,650 		9,596 -1.4% 0.48 US$4,650
2023-08-30 2023-08-29 PlS Planned sale
Rome Zachary
Non-Executive Director
8,792 -2.9%
0.48
US$4,257 		8,792 -2.9% 0.48 US$4,257
2023-08-30 2023-08-28 PrS Proposed sale
Weisman Howard J.

Officer; Chief Executive Officer

Officer
44,131
0.47
US$20,561 		44,131 0.47 US$20,561
2023-08-30 2023-08-28 PrS Proposed sale
Rome Zachary

Officer; Chief Operating Officer

Officer
25,593
0.48
US$12,354 		25,593 0.48 US$12,354
2023-08-30 2023-08-28 PrS Proposed sale
0.5
Derby Michael

Officer; Executive Chairman

Officer
13,540
0.49
US$6,620 		13,540 0.49 US$6,620
2023-08-30 2023-08-28 PlS Planned sale
0.5
Derby Michael
Large shareholder
7,000 -1.5%
0.49
US$3,452 		7,000 -1.5% 0.49 US$3,452
2023-08-30 2023-08-28 PlS Planned sale
LaRochelle Karen
Non-Executive Director
2,000 -3.7%
0.50
US$1,002 		2,000 -3.7% 0.50 US$1,002
2023-08-30 2023-08-28 PlS Planned sale
Coelho John F
Non-Executive Director
774 -1.0%
0.52
US$403 		774 -1.0% 0.52 US$403
2023-08-30 2023-08-28 PlS Planned sale
Weisman Howard J.

Chairman and CEO

Executive Director
12,000 -1.7%
0.49
US$5,858 		12,000 -1.7% 0.49 US$5,858
2023-08-30 2023-08-28 PlS Planned sale
Rome Zachary
Non-Executive Director
12,000 -3.8%
0.49
US$5,862 		12,000 -3.8% 0.49 US$5,862
2023-08-23 2023-08-22 PlS Planned sale
Rome Zachary
Non-Executive Director
30,000 -8.6%
0.54
US$16,236 		30,000 -8.6% 0.54 US$16,236
2023-08-23 2023-08-21 PlS Planned sale
Rome Zachary
Non-Executive Director
20,000 -5.4%
0.58
US$11,626 		20,000 -5.4% 0.58 US$11,626
2023-08-21 2023-08-21 PrS Proposed sale
Rome Zachary

Officer; Chief Operating Officer

Officer
50,000
0.58
US$29,000 		50,000 0.58 US$29,000
2023-03-09 2023-03-09 PlS Planned sale
LaRochelle Karen
Non-Executive Director
335 -0.8%
1.48
US$496 		335 -0.8% 1.48 US$496
2023-03-09 2023-03-09 PlS Planned sale
0.5
Derby Michael

Executive Chairman

Executive Director Large shareholder
2,143 -0.7%
1.43
US$3,064 		2,143 -0.7% 1.43 US$3,064
2023-03-09 2023-03-09 PlS Planned sale
Weisman Howard J.

Chief Executive Officer

Executive Director
3,495 -0.6%
1.44
US$5,033 		3,495 -0.6% 1.44 US$5,033
2023-03-09 2023-03-09 PlS Planned sale
Rome Zachary

Chief Operating Officer

Executive Director
3,371 -1.2%
1.44
US$4,854 		3,371 -1.2% 1.44 US$4,854
2023-03-09 2023-03-09 PlS Planned sale
Coelho John F
Non-Executive Director
130 -0.2%
1.48
US$192 		130 -0.2% 1.48 US$192
2023-03-09 2023-03-08 PlS Planned sale
Weisman Howard J.

Chief Executive Officer

Executive Director
32,397 -5.6%
1.46
US$47,300 		32,397 -5.6% 1.46 US$47,300
2023-03-09 2023-03-08 PlS Planned sale
Rome Zachary

Chief Operating Officer

Executive Director
30,034 -9.3%
1.47
US$44,150 		30,034 -9.3% 1.47 US$44,150
2023-03-07 2023-03-07 PlS Planned sale
Rome Zachary

Chief Operating Officer

Executive Director
23,432 -6.8%
1.53
US$35,851 		23,432 -6.8% 1.53 US$35,851
2023-03-07 2023-03-07 PlS Planned sale
Weisman Howard J.

Chief Executive Officer

Executive Director
23,551 -3.9%
1.53
US$36,033 		23,551 -3.9% 1.53 US$36,033
2023-03-07 2023-03-07 PlS Planned sale
0.5
Derby Michael

Executive Chairman

Executive Director Large shareholder
15,134 -4.4%
1.55
US$23,458 		15,134 -4.4% 1.55 US$23,458
2023-03-07 2023-03-06 PlS Planned sale
Rome Zachary

Chief Operating Officer

Executive Director
13,560 -3.8%
1.72
US$23,323 		13,560 -3.8% 1.72 US$23,323
2023-03-07 2023-03-06 PlS Planned sale
Weisman Howard J.

Chief Executive Officer

Executive Director
13,589 -2.2%
1.72
US$23,373 		13,589 -2.2% 1.72 US$23,373
2023-03-07 2023-03-06 PlS Planned sale
0.5
Derby Michael

Executive Chairman

Executive Director Large shareholder
13,828 -3.9%
1.72
US$23,784 		13,828 -3.9% 1.72 US$23,784
2023-03-03 2023-03-03 PlS Planned sale
LaRochelle Karen
Non-Executive Director
1,097 -2.5%
1.90
US$2,084 		1,097 -2.5% 1.90 US$2,084
2023-03-03 2023-03-03 PlS Planned sale
0.5
Derby Michael

Executive Chairman

Executive Director Large shareholder
18,968 -5.1%
1.90
US$36,039 		18,968 -5.1% 1.90 US$36,039
2023-03-03 2023-03-03 PlS Planned sale
Weisman Howard J.

Chief Executive Officer

Executive Director
15,323 -2.4%
1.90
US$29,114 		15,323 -2.4% 1.90 US$29,114
2023-03-03 2023-03-03 PlS Planned sale
Rome Zachary

Chief Operating Officer

Executive Director
13,199 -3.5%
1.89
US$24,946 		13,199 -3.5% 1.89 US$24,946
2023-03-03 2023-03-02 PlS Planned sale
LaRochelle Karen
Non-Executive Director
7,736 -15.0%
1.94
US$15,008 		7,736 -15.0% 1.94 US$15,008
2023-03-03 2023-03-02 PlS Planned sale
0.5
Derby Michael

Executive Chairman

Executive Director Large shareholder
10,497 -2.7%
1.94
US$20,364 		10,497 -2.7% 1.94 US$20,364
2023-03-03 2023-03-02 PlS Planned sale
Weisman Howard J.

Chief Executive Officer

Executive Director
11,679 -1.8%
1.94
US$22,657 		11,679 -1.8% 1.94 US$22,657
2023-03-03 2023-03-02 PlS Planned sale
Coelho John F
Non-Executive Director
3,013 -4.3%
1.93
US$5,815 		3,013 -4.3% 1.93 US$5,815
2023-03-03 2023-03-02 PlS Planned sale
Rome Zachary

Chief Operating Officer

Executive Director
12,952 -3.4%
1.94
US$25,127 		12,952 -3.4% 1.94 US$25,127
2022-09-01 2022-08-30 B Purchase
0.5
TardiMed Sciences LLC
Large shareholder
95,000 +1.3%
5.25
US$498,750 		95,000 +1.3% 5.25 US$498,750
2022-09-01 2022-08-30 B Purchase
0.5
Derby Michael

Executive Chairman

Executive Director Large shareholder
95,000 +1.3%
5.25
US$498,750 		95,000 +1.3% 5.25 US$498,750
Explore more

More insider trading research around Kuvatris Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America